AMERICAN CANCER SOCIETY H-1B Visa Sponsorship & Salary Data

The median H-1B salary at AMERICAN CANCER SOCIETY is $87,485, based on 46 certified filings from FY 2020 to FY 2026. This is 27% lower than the national H-1B median salary of $120,000. Compensation at AMERICAN CANCER SOCIETY reflects their market positioning, with entry-level roles starting around $69,430 and senior positions reaching $128,378 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at AMERICAN CANCER SOCIETY range from $62,483 at the 10th percentile to $128,378 at the 90th percentile, showing a $65,895 spread across experience levels and roles. The 25th percentile is $69,430 and the 75th percentile is $105,227.

Yes, AMERICAN CANCER SOCIETY actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), AMERICAN CANCER SOCIETY filed 3 H-1B labor condition applications with 3 certified and 0 denied, at a median salary of $62,483. Across FY 2020–2026, they have filed 46 total H-1B applications with 46 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. AMERICAN CANCER SOCIETY sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), AMERICAN CANCER SOCIETY filed 3 H-1B applications, with 3 certified and 0 denied. Over 7 years of data, AMERICAN CANCER SOCIETY has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

AMERICAN CANCER SOCIETY's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 46 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating AMERICAN CANCER SOCIETY as a potential H-1B sponsor.

This is an excellent approval rate, indicating AMERICAN CANCER SOCIETY has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

AMERICAN CANCER SOCIETY sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 46 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles AMERICAN CANCER SOCIETY most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at AMERICAN CANCER SOCIETY:

The most frequently sponsored role is Principal Research Scientist with 12 filings at a median salary of $104,550. This is followed by Associate Research Scientist (7 filings) and Senior Research Scientist.

AMERICAN CANCER SOCIETY's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where AMERICAN CANCER SOCIETY sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top AMERICAN CANCER SOCIETY H-1B locations:

The largest H-1B hub for AMERICAN CANCER SOCIETY is Atlanta, GA with 14 filings at a median salary of $76,336. The highest-paying location is Chicago, IL at $148,949 median. Salaries range from $75,670 to $148,949 across office locations.

AMERICAN CANCER SOCIETY's median H-1B salary has changed by -26% from FY 2020 ($84,365) to FY 2026 ($62,483). Tracking salary trends over time reveals how AMERICAN CANCER SOCIETY adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at AMERICAN CANCER SOCIETY.

Year-by-year breakdown:

• FY 2022: $75,670 (4 certified)
• FY 2023: $92,394 (10 certified)
• FY 2024: $76,336 (7 certified)
• FY 2025: $97,032 (12 certified)
• FY 2026: $62,483 (3 certified)

Salary levels have remained relatively stable at AMERICAN CANCER SOCIETY.

AMERICAN CANCER SOCIETY primarily files H-1B applications at Wage Level II, accounting for 33% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making AMERICAN CANCER SOCIETY's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 87% of positions at Level II or higher, AMERICAN CANCER SOCIETY typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

AMERICAN CANCER SOCIETY's median H-1B salary of $87,485 is 27% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating AMERICAN CANCER SOCIETY's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare AMERICAN CANCER SOCIETY's offerings with similar companies in your field for a more accurate assessment.

AMERICAN CANCER SOCIETY's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. AMERICAN CANCER SOCIETY's higher proportion of Level III-IV positions (54%) may benefit from wage-based lottery prioritization.

With 46 certified filings, AMERICAN CANCER SOCIETY invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.